← Eichor
Condition: Cervix Uteri Sil Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cervix Uteri Sil

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396Regression of Cervical Precancerous Lesions and Associated Risk Factors
Phase N/A · 1 location(s) · General University Hospital, Prague · NCT06147388A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NA · 1 location(s) · Timser SAPI de CV · NCT07480902Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT04783805
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.